Q1WB
EW icon

Quest 10 Wealth Builders’s Edwards Lifesciences EW Stock Holding History

Quest 10 Wealth Builders’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.29K Hold
116
– – 0.01% 456
2025
Q4 		$9.89K Hold
116
– – 0.01% 414
2025
Q3 		$9.02K Sell
116
-83
-42% -$6.49K 0.01% 390
2025
Q2 		$15.6K Hold
199
– – 0.02% 341
2025
Q1 		$14.4K Buy
199
+83
+72% +$5.94K 0.02% 318
2024
Q4 		$8.59K Buy
+116
New +$8.12K 0.01% 413

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quest 10 Wealth Builders's EW Position: Q1 2026 in Review

Quest 10 Wealth Builders held its Edwards Lifesciences (EW) position steady in Q1 2026 at 116 shares worth $9.29K. The position accounts for 0.01% of the portfolio, ranked #456.

Quest 10 Wealth Builders first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.6K in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Quest 10 Wealth Builders held 116 shares of Edwards Lifesciences worth $9.29K as of Q1 2026.
  • Quest 10 Wealth Builders left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.01% of Quest 10 Wealth Builders's portfolio in Q1 2026, its #456 holding.
  • Quest 10 Wealth Builders first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Quest 10 Wealth Builders's Edwards Lifesciences position peaked at $15.6K in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q1 2026, filed 6 May 2026.